UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Molecular inhibition of RAS signalling to target ageing and age-related health

Laskovs, Mihails; Partridge, Linda; Slack, Cathy; (2022) Molecular inhibition of RAS signalling to target ageing and age-related health. Disease Models & Mechanisms , 15 (10) , Article dmm049627. 10.1242/dmm.049627. Green open access

[thumbnail of Partridge_Molecular inhibition of RAS signalling to target ageing and age-related health_VoR.pdf]
Preview
Text
Partridge_Molecular inhibition of RAS signalling to target ageing and age-related health_VoR.pdf - Published Version

Download (1MB) | Preview

Abstract

The RAS/MAPK pathway is a highly conserved signalling pathway with a well-established role in cancer. Mutations that hyperactivate this pathway are associated with unregulated cell proliferation. Evidence from a range of model organisms also links RAS/MAPK signalling to ageing. Genetic approaches that reduce RAS/MAPK signalling activity extend lifespan and also improve healthspan, delaying the onset and/or progression of age-related functional decline. Given its role in cancer, therapeutic interventions that target and inhibit this pathway's key components are under intense investigation. The consequent availability of small molecule inhibitors raises the possibility of repurposing these compounds to ameliorate the deleterious effects of ageing. Here, we review evidence that RAS/MAPK signalling inhibitors already in clinical use, such as trametinib, acarbose, statins, metformin and dihydromyricetin, lead to lifespan extension and to improved healthspan in a range of model systems. These findings suggest that the repurposing of small molecule inhibitors of RAS/MAPK signalling might offer opportunities to improve health during ageing, and to delay or prevent the development of age-related disease. However, challenges to this approach, including poor tolerance to treatment in older adults or development of drug resistance, first need to be resolved before successful clinical implementation.

Type: Article
Title: Molecular inhibition of RAS signalling to target ageing and age-related health
Open access status: An open access version is available from UCL Discovery
DOI: 10.1242/dmm.049627
Publisher version: https://doi.org/10.1242/dmm.049627
Language: English
Additional information: © 2022. Published by The Company of Biologists Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Keywords: MEK inhibitor, RAS pathway, Ageing
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences > Genetics, Evolution and Environment
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences
URI: https://discovery.ucl.ac.uk/id/eprint/10156006
Downloads since deposit
19Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item